BI NA-XILab Mol Targeted Therapy Oncol Sichuan Univ关注立即认领分享关注立即认领分享基本信息浏览量:0职业迁徙个人简介暂无内容研究兴趣论文共 2 篇作者统计合作学者相似作者按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选时间引用量主题期刊级别合作者合作机构Abstract. Mutant KRAS and BRAF are associated with primary EGFR inhibitor resistance in colorectal cancer (CRC). However, other biomarkers that could predict EGFR inhibitor resistance remain elusive. In the present study, immunoblotting and cell proliferation results revealed that yes-associated proBI-SHENG LIU,HONG-WEI XIA,SHENG ZHOU,QING LIU,QIU-LIN TANG,BI NA-XI,JI-TAO ZHOU,QI-YONG GONG,YONG-ZHAN NIE,BI FENGsemanticscholar(2018)引用0浏览0引用00Inhibition of YAP reverses primary resistance to EGFR inhibitors in colorectal cancer cellsBi-Sheng Liu,Hong-Wei Xia,Sheng Zhou,Qing Liu,Qiu-Lin Tang,Na-Xi Bi,Ji-Tao Zhou,Qi-Yong Gong,Yong-Zhan Nie,Feng BiONCOLOGY REPORTS(2018)引用26浏览0WOS引用260作者统计合作学者合作机构D-Core合作者学生导师暂无相似学者,你可以通过学者研究领域进行搜索筛选数据免责声明页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn